STOCKHOLM, March 2, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that it has received approval by FDA for its supplement to extend the labelling to include other healthcare...
Hence then, the article about scibase receives approval by fda for extended labelling in the us was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SciBase receives approval by FDA for extended labelling in the US )
Also on site :
- Menu-Order-AI Surpasses 110,000 Downloads as It Targets the Biggest Gap in the GLP-1 Era: What to Order
- Happy's Place Boss Teases Season 3 Plans: More Bemmett, More Jane Lynch... And More Of Steve Howey And JoAnna Garcia?
- 75 Gorgeous Turkish Names for Girls and Boys